Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Shares Outstanding (Weighted Average) (2022 - 2025)

Praxis Precision Medicines has reported Shares Outstanding (Weighted Average) over the past 4 years, most recently at $704225.0 for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $704225.0 for Q4 2025, down 96.07% from a year ago — trailing twelve months through Dec 2025 was $704225.0 (down 96.07% YoY), and the annual figure for FY2025 was $704225.0, down 22.15%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $704225.0 at Praxis Precision Medicines, roughly flat from $704225.0 in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for PRAX hit a ceiling of $45.8 million in Q3 2022 and a floor of $704225.0 in Q3 2025.
  • Median Shares Outstanding (Weighted Average) over the past 4 years was $10.2 million (2023), compared with a mean of $15.9 million.
  • Peak annual rise in Shares Outstanding (Weighted Average) hit 2250.98% in 2025, while the deepest fall reached 96.07% in 2025.
  • Praxis Precision Medicines' Shares Outstanding (Weighted Average) stood at $3.1 million in 2022, then soared by 114.58% to $6.6 million in 2023, then soared by 171.55% to $17.9 million in 2024, then plummeted by 96.07% to $704225.0 in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $704225.0 (Q4 2025), $704225.0 (Q3 2025), and $21.3 million (Q2 2025) per Business Quant data.